» Articles » PMID: 37165007

Platelet Function Suggests Cardioembolic Aetiology in Cryptogenic Stroke

Overview
Journal Sci Rep
Specialty Science
Date 2023 May 10
PMID 37165007
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-monocyte (PMA) and platelet-neutrophil aggregations (PNA) play critical roles in the evolution of acute ischemic stroke (AIS). The present study investigates the mechanistic basis of platelet responsiveness in cryptogenic stroke compared with cardioembolic stroke. Platelet from 16 subjects, each from cryptogenic and cardioembolic stroke groups and 18 age-matched healthy controls were subjected to different investigations. Compared to healthy controls, platelet-monocyte and platelet-neutrophil interactions were significantly elevated in cryptogenic (2.7 and 2.1 times) and cardioembolic stroke (3.9 and 2.4 times). P-selectin expression on platelet surface was 1.89 and 2.59 times higher in cryptogenic and cardioembolic strokes, respectively, compared to healthy control. Cell population with [Ca] in either stroke group was significantly outnumbered (by 83% and 72%, respectively, in cryptogenic and cardioembolic stroke) in comparison to healthy controls. Noteworthy, TEG experiment revealed that the cryptogenic stroke exhibited significant decline in Reaction Time (R) and amplitude of 20 mm (K) (by 32% and 33%, respectively) while thrombin burst (α-angle) was augmented by 12%, which reflected substantial boost in thrombus formation in cryptogenic stroke. Although TEG analysis reveals a state of hypercoagulability in patients with cryptogenic stroke. However, platelets from both stroke subtypes switch to a 'hyperactive' phenotype.

Citing Articles

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate.

Matsumoto T, Wada H, Shiraki K, Suzuki K, Yamashita Y, Tawara I J Clin Med. 2023; 12(19).

PMID: 37834964 PMC: 10573981. DOI: 10.3390/jcm12196320.

References
1.
Grau A, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H . Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost. 1998; 80(2):298-301. View

2.
Tan Y, Zhan L, Chen X, Guo J, Qin C, Xu E . Risk Factors, Clinical Features and Prognosis for Subtypes of Ischemic Stroke in a Chinese Population. Curr Med Sci. 2018; 38(2):296-303. DOI: 10.1007/s11596-018-1878-1. View

3.
Guzik A, Bushnell C . Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017; 23(1, Cerebrovascular Disease):15-39. DOI: 10.1212/CON.0000000000000416. View

4.
Zaid Y, Merhi Y . Implication of Platelets in Immuno-Thrombosis and Thrombo-Inflammation. Front Cardiovasc Med. 2022; 9:863846. PMC: 8990903. DOI: 10.3389/fcvm.2022.863846. View

5.
Zarbock A, Polanowska-Grabowska R, Ley K . Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2006; 21(2):99-111. DOI: 10.1016/j.blre.2006.06.001. View